This information is intended for US healthcare professionals.

Brought to you by Gilead Oncology logo in white text.

HEAR EXPERT PERSPECTIVES REVIEW THE CLUES

Hear insights from experts about the case against higher-risk MDS

Physicians spoke in their personal capacity, and their views may not reflect those of their institutions.
A video discussing the challenges of higher-risk MDS.

The Challenges of Higher-Risk MDS

A video discussing immunity in the bone marrow microenvironment.

Innate and Adaptive Immunity in the MDS Bone Marrow Microenvironment

A video sharing treatment goals for patients with higher-risk MDS.

A Patient-Centric Perspective on Goals of Treatment & Management of HR-MDS

A video discussing the immune system in higher-risk MDS.

Unlocking the Immune System in HR-MDS

Be sure to get updates from Gilead as the case evolves

Register
for Updates

HR-MDS, higher-risk myelodysplastic syndrome; MDS, myelodysplastic syndrome.